MB Therapeutics Overview
- Year Founded
-
2023
- Status
-
Private
- Employees
-
10
- Latest Deal Type
-
Series A
- (Cancelled)
- Investors
-
6
MB Therapeutics General Information
Description
Operator of a pharmaceutical company intended to provide personalized medicine through healthcare three-D printing. The company offers patient-centric system for developing and producing customized medicines as well as evaluation services and specializes in customizing medication dosage, forms, and combining multiple active ingredients into a single unit, enabling healthcare professionals to enhance treatment precision and improving patient adherence.
Contact Information
Website
mb-therapeutics.comCorporate Office
- 505b, Rue Louis Lepine
- 34000 Montpellier
- France
Corporate Office
- 505b, Rue Louis Lepine
- 34000 Montpellier
- France
MB Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Early Stage VC (Series A) | 24-Feb-2025 | Cancelled | Generating Revenue | |||
| 3. Early Stage VC | Completed | Generating Revenue | ||||
| 2. Early Stage VC | 24-Feb-2025 | $2.08M | $2.08M | Completed | Generating Revenue | |
| 1. Accelerator/Incubator | 01-Jan-2023 | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
MB Therapeutics Patents
MB Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025247979-A1 | Extrusion-printable pharmaceutical formulation, print cartridge containing such a formulation and method for preparing a medicament using same | Pending | 30-May-2024 | ||
| FR-3162625-A1 | Extrusion-printable pharmaceutical formulation, printing cartridge containing such a formulation, and process for preparing a medicinal product using it | Pending | 30-May-2024 |
MB Therapeutics Signals
MB Therapeutics Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Angels Santé | Angel Group | Minority | ||
| Banque Publique d'Investissement | Investment Bank | Minority | ||
| Beprep | Venture Capital | Minority | ||
| Calyseed | Venture Capital | Minority | ||
| Angel (individual) | Minority |
MB Therapeutics FAQs
-
When was MB Therapeutics founded?
MB Therapeutics was founded in 2023.
-
Where is MB Therapeutics headquartered?
MB Therapeutics is headquartered in Montpellier, France.
-
What is the size of MB Therapeutics?
MB Therapeutics has 10 total employees.
-
What industry is MB Therapeutics in?
MB Therapeutics’s primary industry is Other Pharmaceuticals and Biotechnology.
-
Is MB Therapeutics a private or public company?
MB Therapeutics is a Private company.
-
What is MB Therapeutics’s current revenue?
The current revenue for MB Therapeutics is .
-
How much funding has MB Therapeutics raised over time?
MB Therapeutics has raised $2.67M.
-
Who are MB Therapeutics’s investors?
Angels Santé, Banque Publique d'Investissement, Beprep, Calyseed, and are 5 of 6 investors who have invested in MB Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process